Influenza Vaccine for 2024-2025

Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication.1,2 Influenza vaccines available in the US for the 2024-2025 season are listed in Table 2.

Publication Details

Journal
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Published
2024-09-16
DOI
https://doi.org/10.58347/tml.2024.1711a
Citations
1
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Influenza Vaccine for 2024-2025

1 citations
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Influenza Virus Research Studies
0.39
article

Influenza Vaccine for 2024-2025

article en
1 citations

Abstract

Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication.1,2 Influenza vaccines available in the US for the 2024-2025 season are listed in Table 2.

˜The œmedical letter on drugs and therapeutics/˜The œmedical letterVol. 66(1711)
Good health and well-being
Openalex Percentile: Top 34%
Influenza Virus Research Studies
0.39
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Influenza Vaccine for 2024-2025 · ˜The œmedical letter on drugs and therapeutics/˜The œmedical letter (2024) | TGRS Research Map | TGRS